Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FRAUD AND ABUSE—6th Cir.: Unlicensed nurse’s patient-care duties justified sentencing enhancement for risk of serious bodily injury
    • ANTI-KICKBACK PROHIBITION—SETTLEMENT AGREEMENTS: New Jersey lab testing service agrees to pay over $13 million to settle false claims allegations
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—FINAL RULES: 3-CMC gets separate Schedule I drug code
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—NOTICES: DEA sets course for 2027 drug production
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COST REPORTS—OIG REPORTS: Medicare Cost Report oversight failed to detect obvious settlement errors
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—New Jersey bill would treat AI chatbots as products and impose strict liability on chatbot providers
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD STANDARDS—FINAL RULES: FDA scrubs abandoned solvents from color additive rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD STANDARDS—FINAL RULES: Three solvents out under FDA color additive action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND ABUSE—E.D.N.Y.: Healthcare fraud suspect interviewed at home could not suppress contradictory statements in criminal trial
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Congestion-relief stimulators get Class II classification
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—NOTICES: DEA sets course for 2027 drug production, (Nov 13, 2026)

    By WK Editorial Staff

    DEA’s proposal incorporates projected demand, inventory needs, drug-shortage concerns, and diversion estimates to determine how much of each covered substance may be manufactured in 2027.

    The Drug Enforcement Administration (DEA) proposed 2027 ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use